Valuation: Fresenius SE & Co. KGaA

Capitalization 2.36TCr 2.76TCr 2.2TCr 2.05TCr 3.78TCr 2,37000Cr 4.2TCr 26TCr 10TCr 1,11000Cr 10TCr 10TCr 4,07100Cr P/E ratio 2025 *
15.2x
P/E ratio 2026 * 12.7x
Enterprise value 3.49TCr 4.08TCr 3.25TCr 3.02TCr 5.58TCr 3,50000Cr 6.21TCr 39TCr 15TCr 1,63900Cr 15TCr 15TCr 6,01100Cr EV / Sales 2025 *
1.54x
EV / Sales 2026 * 1.43x
Free-Float
73.04%
Yield 2025 *
2.5%
Yield 2026 * 2.72%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.66%
1 week-1.27%
Current month-1.73%
1 month-5.20%
3 months+14.68%
6 months+19.56%
Current year+25.04%
More quotes
1 week 41.48
Extreme 41.48
42.75
1 month 41.41
Extreme 41.41
44.38
Current year 31.6
Extreme 31.6
44.4
1 year 28.65
Extreme 28.65
44.4
3 years 19.69
Extreme 19.69
44.4
5 years 19.69
Extreme 19.69
47.6
10 years 19.69
Extreme 19.69
80.07
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 01/10/2022
Director of Finance/CFO 45 01/09/2022
Compliance Officer 48 -
Director TitleAgeSince
Director/Board Member 70 20/05/2015
Director/Board Member 64 13/05/2016
Director/Board Member 51 01/01/2008
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.66%-1.27%+42.90%+48.72% 2.76TCr
-0.59%-0.14%+15.96%+121.07% 9.05TCr
-1.28%-3.93%+9.80%-31.80% 8.19TCr
-0.23%-1.71%-5.77%+36.29% 2.47TCr
-1.58%-4.69%+21.07%+4.05% 2.09TCr
-1.96%-4.99%+16.64%+25.36% 1.88TCr
+1.20%+2.48%+30.78%+226.92% 1.63TCr
-1.45%-3.16%+25.64%-1.80% 1.59TCr
-2.56%-6.02%+35.50%+233.21% 1.38TCr
-1.51%-4.67%+15.07%+13.00% 1.32TCr
Average -1.06%-2.35%+20.76%+67.50% 3.24TCr
Weighted average by Cap. -0.96%-2.05%+17.43%+56.30%
See all sector performances

Financials

2025 *2026 *
Net sales 2.27TCr 2.66TCr 2.11TCr 1.97TCr 3.63TCr 2,27800Cr 4.04TCr 25TCr 9.69TCr 1,06700Cr 9.96TCr 9.75TCr 3,91300Cr 2.38TCr 2.79TCr 2.22TCr 2.06TCr 3.81TCr 2,39100Cr 4.24TCr 27TCr 10TCr 1,11900Cr 10TCr 10TCr 4,10600Cr
Net income 153.2Cr 179.15Cr 142.7Cr 132.72Cr 245.23Cr 15TCr 272.53Cr 1.71TCr 653.73Cr 7.2TCr 671.92Cr 658.07Cr 26TCr 186.51Cr 218.11Cr 173.73Cr 161.58Cr 298.56Cr 19TCr 331.79Cr 2.08TCr 795.89Cr 8.76TCr 818.03Cr 801.17Cr 32TCr
Net Debt 1.13TCr 1.32TCr 1.05TCr 975.44Cr 1.8TCr 1,13000Cr 2TCr 13TCr 4.8TCr 53TCr 4.94TCr 4.84TCr 1,94000Cr 1.05TCr 1.23TCr 978.16Cr 909.78Cr 1.68TCr 1,05400Cr 1.87TCr 12TCr 4.48TCr 49TCr 4.61TCr 4.51TCr 1,81000Cr
More financial data * Estimated data
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (39.1%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. ; - other (1.7%).
Employees
1,75,202
More about the company
Date Price Change Volume
11/25/11 41.94 -0.66% 5,41,496
10/25/10 42.22 -0.14% 8,07,441
09/25/09 42.28 +0.69% 6,78,460
08/25/08 41.99 -1.04% 8,78,276
07/25/07 42.43 -0.12% 4,86,707

Delayed Quote Xetra, July 11, 2025 at 09:10 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
41.94EUR
Average target price
48.78EUR
Spread / Average Target
+16.30%
Consensus

Quarterly revenue - Rate of surprise